Cargando…

Beta-lactam antibiotics in continuous infusion in critically ill patients

Detalles Bibliográficos
Autores principales:	Jeurissen, Axel, Rutsaert, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219286/ https://www.ncbi.nlm.nih.gov/pubmed/21062510 http://dx.doi.org/10.1186/cc9288

Ejemplares similares

Continuous infusion of antibiotics in the critically ill: The new holy grail for beta-lactams and vancomycin?
por: Van Herendael, Bruno, et al.
Publicado: (2012)

Continuous beta-lactam infusion in critically ill patients: the clinical evidence
por: Abdul-Aziz, Mohd H, et al.
Publicado: (2012)

Continuous infusion of meropenem in critically ill patients: practical considerations
por: Taccone, Fabio Silvio
Publicado: (2012)

Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy
por: Ulldemolins, Marta, et al.
Publicado: (2014)

Pharmacokinetics–pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients
por: Veiga, Rui Pedro, et al.
Publicado: (2018)

Update on Therapeutic Drug Monitoring of Beta-Lactam Antibiotics in Critically Ill Patients—A Narrative Review
por: Stašek, Jan, et al.
Publicado: (2023)

Beta-Lactam Antibiotic Therapeutic Drug Monitoring in Critically Ill Patients: A Systematic Review and Meta-Analysis
por: Pai Mangalore, Rekha, et al.
Publicado: (2022)

Continuous Vancomycin Infusion versus Intermittent Infusion in Critically Ill Patients
por: Maluangnon, Chailat, et al.
Publicado: (2022)

Impact of an Extended Infusion Β-lactam Strategy on Outcomes in Critically Ill Patients with Pseudomonas Infections
por: Klinker, Kenneth, et al.
Publicado: (2017)

Assessment of a PK/PD Target of Continuous Infusion Beta-Lactams Useful for Preventing Microbiological Failure and/or Resistance Development in Critically Ill Patients Affected by Documented Gram-Negative Infections
por: Gatti, Milo, et al.
Publicado: (2021)

Use of beta-lactams antibiotics in ICU patients
por: Damas, M-P, et al.
Publicado: (2015)

Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams
por: Gonçalves-Pereira, Joao, et al.
Publicado: (2011)

Effectiveness of Extended or Continuous vs. Bolus Infusion of Broad-Spectrum Beta-Lactam Antibiotics for Febrile Neutropenia: A Systematic Review and Meta-Analysis
por: Ishikawa, Kazuhiro, et al.
Publicado: (2023)

1175. Extended Infusion Beta-lactams in Pediatric Patients with Febrile Neutropenia
por: Nagel, Jerod, et al.
Publicado: (2023)

Health Care Costs of Target Attainment for Beta-Lactam Antibiotics in Critically Ill Patients: A Retrospective Analysis of the EXPAT Study
por: Ewoldt, Tim M. J., et al.
Publicado: (2022)

Model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin in critically ill patients: a multicentre randomised clinical trial
por: Ewoldt, Tim M. J., et al.
Publicado: (2022)

Statistical analysis plan for the BLING III study: a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis
por: Billot, Laurent, et al.
Publicado: (2023)

Commentary on “Beta-Lactam Antibiotics as A Possible Novel Therapy for Managing Epilepsy and Autism
por: ZHU, Liqin, et al.
Publicado: (2018)

Rationale and evidence for the use of new beta-lactam/beta-lactamase inhibitor combinations and cefiderocol in critically ill patients
por: Barbier, François, et al.
Publicado: (2023)

THE BETA-LACTAM ANTIBIOTICS: Penicillins and Cephalosporins in Perspective
Publicado: (1980)

The Current Status and Future Perspectives of Beta-Lactam Therapeutic Drug Monitoring in Critically Ill Patients
por: Novy, Emmanuel, et al.
Publicado: (2023)

The clinical application of beta-lactam antibiotic therapeutic drug monitoring in the critical care setting
por: Pai Mangalore, Rekha, et al.
Publicado: (2023)

Identifying “at-risk” patients for sub-optimal beta-lactam exposure in critically ill patients with severe infections
por: Abdul-Aziz, Mohd H., et al.
Publicado: (2017)

Relationship Between Real-time TDM-guided Pharmacodynamic Target Attainment of Continuous Infusion Beta-lactam Monotherapy and Microbiologic Outcome in the Treatment of Critically Ill Children With Severe Documented Gram-negative Infections
por: Gatti, Milo, et al.
Publicado: (2023)

Failure of target attainment of beta-lactam antibiotics in critically ill patients and associated risk factors: a two-center prospective study (EXPAT)
por: Abdulla, Alan, et al.
Publicado: (2020)

Cefepime in critically ill patients: continuous infusion versus intermittent regimen
por: Georges, B, et al.
Publicado: (2001)

P1554: SYSTEMATIC REVIEW OF EXTENDED VERSUS BOLUS INFUSION OF BROAD-SPECTRUM BETA-LACTAM ANTIBIOTICS FOR FEBRILE NEUTROPENIA
por: Ishikawa, Kazuhiro, et al.
Publicado: (2023)

Setting the Beta-Lactam Therapeutic Range for Critically Ill Patients: Is There a Floor or Even a Ceiling?
por: Barreto, Erin F., et al.
Publicado: (2021)

Impact of the New Delhi metallo-beta-lactamase on beta-lactam antibiotics
por: Zmarlicka, Monika T, et al.
Publicado: (2015)

Advances in antibiotic therapy in the critically ill
por: Jia, Rufu, et al.
Publicado: (2016)

Beta-lactam antibiotic test doses in the emergency department
por: Maguire, Michelle, et al.
Publicado: (2020)

Suspected allergy to Beta-Lactam antibiotics: An infectiological perspective
por: Sunderkötter, Cord
Publicado: (2022)

Cephalosporins as key lead generation beta-lactam antibiotics
por: Lin, Xuemei, et al.
Publicado: (2022)

Optimal dosing of antibiotics in critically ill patients by using continuous/extended infusions: a systematic review and meta-analysis
por: Chant, Clarence, et al.
Publicado: (2013)

A pilot study of the pharmacokinetics of continuous magnesium infusion in critically ill patients
por: Chan, Jian Wen, et al.
Publicado: (2023)

Continuous capnography monitoring during transport of critically ill patients
por: Venkatesan, Kumaresh
Publicado: (2016)

Beta-Lactams Dosing in Critically Ill Patients with Gram-Negative Bacterial Infections: A PK/PD Approach
por: Maguigan, Kelly L., et al.
Publicado: (2021)

318. Beta-lactam Therapeutic Drug Monitoring Improves Attainment of Target Drug Levels in Critically Ill Patients
por: Ausman, Sara, et al.
Publicado: (2023)

Effects of continuous ketamine infusion on hemodynamics and mortality in critically ill children
por: Park, Sojin, et al.
Publicado: (2019)

Continuous infusion versus intermittent infusion of vancomycin in critically ill patients undergoing continuous venovenous hemofiltration: a prospective interventional study
por: Xu, Jinhui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0vmo9h59173h1a2b0pdhlojsdf